Search results
Results from the WOW.Com Content Network
cdsco.gov.in and www.cdscoonline.gov.in The Central Drugs Standard Control Organisation ( CDSCO ) is India 's national regulatory body for cosmetics , pharmaceuticals and medical devices . It serves a similar function to the Food and Drug Administration (FDA) of the United States or the European Medicines Agency of the European Union .
Open Government Data (OGD) Platform India [1] [2] or data.gov.in is a platform for supporting Open data initiative of Government of India. This portal is a single-point access to datasets, documents, services, tools and applications published by ministries, departments and organisations of the Government of India .
Senior status Appointed by Reason for termination — Leon Rene Yankwich: CA: 1888–1975 — — 1966–1975 [Note 1] F. Roosevelt/Operation of law: death — William Matthew Byrne Sr. CA: 1896–1974 — — 1966–1974 [Note 1] Truman/Operation of law: death 1 Peirson Mitchell Hall: CA: 1894–1979 1966–1968 [Note 1] — 1968–1979 F ...
Status-Dependent_Selection.pdf (762 × 489 pixels, file size: 30 KB, MIME type: application/pdf) This is a file from the Wikimedia Commons . Information from its description page there is shown below.
The crypto exchange's move comes amid a broader industry push to lobby lawmakers for a regulatory framework to support the sector's growth. Most traditional U.S. banks have steered clear of ...
The UK Government publishes annual accounts for the whole of government. [1] It aims to provide more complete data for fiscal planning by producing consolidated financial statements. The accounts are produced in accordance with the International Financial Reporting Standards and independently audited by the Comptroller and Auditor General. [2]
The Development Monitoring and Evaluation Office (DMEO) under the NITI Aayog is responsible for evaluations. [15] Evaluation problems exist. [15] Ministries such as the transport ministry can show immediate physical outcomes of its schemes whereas in health related schemes, in certain cases, there is no output to show for. [15]
From April 2009 to December 2012, if you bought shares in companies when John S. Watson joined the board, and sold them when he left, you would have a 58.3 percent return on your investment, compared to a 75.8 percent return from the S&P 500.